Search clinical trials for: SOM230
Total 50 results
-
Lynn FeunCompletedHepatocellular CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedCushing's DiseaseItaly, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedNeuroendocrine Carcinoma of the Lung and ThymusItaly, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
-
Novartis PharmaceuticalsCompletedRenal ImpairmentGermany, South Africa
-
Novartis PharmaceuticalsCompletedCastration Resistant Prostate CancerGermany
-
RECORDATI GROUPCompletedCushings DiseaseCanada, France, Germany, Italy, United States, Israel, Romania, Colombia, Lebanon, Netherlands, United Kingdom
-
Cedars-Sinai Medical CenterNovartisWithdrawn
-
Novartis PharmaceuticalsTerminatedCluster Headache - Episodic and ChronicUnited States, United Kingdom, Germany
-
Novartis PharmaceuticalsCompletedCushing's SyndromeUnited States
-
Robert R. Henry, MDVeterans Medical Research FoundationCompletedHyperglycemiaUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompletedPostoperative Dumping SyndromeBelgium
-
Montefiore Medical CenterNo longer availableCongenital HyperinsulinismUnited States
-
Novartis PharmaceuticalsCompletedDose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)Neuroendocrine TumorsUnited States
-
University of PennsylvaniaTerminatedGonadotroph AdenomasUnited States
-
Novartis PharmaceuticalsTerminatedPituitary Neoplasm | Pancreatic Neoplasm | Ectopic ACTH Syndrome | Nelson SyndromeGermany, Italy, Australia, Russian Federation, Spain, Thailand, France, Canada, Brazil, United States, Argentina, Mexico
-
Novartis PharmaceuticalsCompletedAcromegalyItaly, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
-
Novartis PharmaceuticalsCompletedAcromegaly | Pituitary GigantismJapan
-
Novartis PharmaceuticalsCompletedDumping SyndromeBelgium, Netherlands, Germany, France, United States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedPancreatic CancerUnited States
-
Novartis PharmaceuticalsApproved for marketing
-
Novartis PharmaceuticalsCompletedAcromegalyItaly, Australia, Belgium, Germany, Switzerland, United States, France
-
Prof. Dr. Berthold SchalkeCrolll GmbhCompletedPrimary Inoperable Thymoma | Local Recurrent ThymomaGermany
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedCushing DiseaseUnited States, Italy, France, Germany, United Kingdom
-
Novartis PharmaceuticalsCompletedCushing's DiseaseUnited States, Germany, Korea, Republic of, Spain, Thailand, Lebanon, Romania, Greece, Brazil, Russian Federation, Czechia
-
Montefiore Medical CenterNovartis PharmaceuticalsWithdrawnHyperinsulinism | Insulinoma | Congenital Hyperinsulinism
-
University of UtahNovartisTerminated
-
Patrick Y. Wen, MDMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Northwestern... and other collaboratorsCompleted
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States, Germany, Italy, Belgium, Taiwan, Turkey, Switzerland, Israel, Netherlands, Sweden, United Kingdom, Korea, Republic of, Spain, France, Canada, Greece, Russian Federation, Denmark, Mexico, China, Hungary, Norway, Argentina and more
-
Erasmus Medical CenterNovartisUnknown
-
Federico II UniversityCompletedMedullary Thyroid CancerItaly
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States
-
Emory UniversityNovartisCompletedThyroid CancerUnited States
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States
-
Bruin Biometrics, LLCCompletedPressure UlcersUnited States
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedEverolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States, Italy, Belgium, Saudi Arabia, Spain, France, Germany, Canada, United Kingdom, Colombia, Brazil, Israel, Turkey, Romania, Norway, Poland, Russian Federation, Argentina
-
Emory UniversityNovartisCompletedNeuroendocrine TumorsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Novartis PharmaceuticalsTerminatedProstate Cancer | Castrate Resistant Prostate Cancer | Chemotherapy Naive Prostate CancerUnited States
-
RECORDATI GROUPActive, not recruitingProstate Cancer | Neuroendocrine Tumors | Acromegaly | Cushing's Disease | Dumping Syndrome | Pituitary Tumors | Ectopic ACTH Secreting (EAS) Tumors | Melanoma Negative for bRAF | Melanoma Negative for nRASBelgium, Brazil, Bulgaria, Canada, France, Germany, Italy, Japan, Korea, Republic of, Thailand, Turkey, United States, Argentina, Greece, Hungary, India, Israel, Malaysia, Mexico, Netherlands, Peru, Poland, Portugal, Romania, Russian Federation and more
-
Novartis PharmaceuticalsCompletedAcromegaly | Cushing's DiseaseUnited States, Turkey, Belgium, Thailand, Germany, Denmark, Russian Federation, Peru, China, Brazil, India, Poland
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of PittsburghNovartisWithdrawnMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States